KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 252 filers reported holding KITE PHARMA INC in Q3 2017. The put-call ratio across all filers is 1.40 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $8,812,000 | -12.3% | 85,000 | -33.6% | 0.55% | -17.4% |
| Q1 2017 | $10,047,000 | +75.0% | 128,000 | 0.0% | 0.66% | +78.3% |
| Q4 2016 | $5,740,000 | -30.9% | 128,000 | -13.9% | 0.37% | -26.4% |
| Q3 2016 | $8,301,000 | +11.7% | 148,600 | 0.0% | 0.51% | +11.4% |
| Q2 2016 | $7,430,000 | +8.9% | 148,600 | 0.0% | 0.46% | +19.4% |
| Q1 2016 | $6,822,000 | -25.5% | 148,600 | 0.0% | 0.38% | -16.8% |
| Q4 2015 | $9,157,000 | +17.5% | 148,600 | +6.1% | 0.46% | +1.1% |
| Q3 2015 | $7,795,000 | – | 140,000 | – | 0.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,410,034 | $433,348,000 | 77.71% |
| COWEN INC. | 4,200,600 | $755,310,000 | 26.72% |
| Tyrus Capital S.A.M. | 1,314,812 | $236,416,000 | 18.49% |
| OMNI PARTNERS LLP | 661,711 | $118,982,000 | 15.19% |
| FNY Partners Fund LP | 379,510 | $68,239,000 | 11.61% |
| EQUITEC PROPRIETARY MARKETS, LLC | 240,100 | $43,172,000 | 10.15% |
| EQUITEC PROPRIETARY MARKETS, LLC | 227,500 | $40,907,000 | 9.62% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 773,817 | $139,140,000 | 8.89% |
| Quad Capital Management Advisors LLC | 192,537 | $34,620,000 | 7.10% |
| Avoro Capital Advisors LLC | 496,983 | $89,363,000 | 6.93% |